Navigation Links
CenTrak, a Leading Real-Time Location System Provider, Unveils New Branding
Date:11/3/2011

NEWTOWN, Pa., Nov. 3, 2011 /PRNewswire/ -- CenTrak, a leading Real-Time Location System provider for healthcare, is pleased to unveil its new brand positioning – The Smarter Real-Time Location System. The new messaging better captures all of the inherent advantages of the CenTrak RTLS

  • Industry-Leading Accuracy, Performance and Battery Life
  • Open Platform to Support Multiple Applications
  • Easy Installation and Maintenance

(Logo: http://photos.prnewswire.com/prnh/20111103/PH99163LOGO)

The new branding has been executed in all key foundational elements including the company's external website (www.centrak.com). 

"The new brand more closely captures CenTrak's personality, as well as our commitment to quality and performance – both being second-to-none. It positions us for continued growth and audience mindshare," said Dr. Ari Naim, CEO and Co-founder of CenTrak.

Adam Peck, Director of Marketing, who started at CenTrak in May 2011, drove the strategy for the new brand look and feel. "The new brand more clearly communicates the significant advantages and unique attributes inherent in the CenTrak infrastructure vital to growth of our industry. My first priority has been to establish a means to help expand the healthcare industry's understanding of the multitude of uses for real-time locating while demonstrating how CenTrak through unparalleled innovation, commitment to product quality and performance is enabling them."

About CenTrak

CenTrak™ is The Smarter Real-Time Location System™ (RTLS) – the leading provider of precise, adaptable, and cost-effective location solutions for healthcare facilities. The patented CenTrak Hybrid RTLS Technology™ uniquely combines Gen2IR and active RFID technologies to deliver certainty-based location data, a requirement for workflow and other key healthcare management applications. CenTrak delivers unmatched speed, performance and power-efficiency making it a smarter technology investment. As the only predominantly battery-powered RTLS network, CenTrak™ offers easy installation (no in-room wiring) as well as affordable enterprise-wide scalability. The CenTrak RTLS is in-use in over 15 million square feet of world-class healthcare facilities spanning three continents.

 


'/>"/>
SOURCE CenTrak
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
2. Leading Biopharmas Will Deliver Case Studies on Achieving Productivity Excellence through Engagement, Technology, Other Tools
3. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
4. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
5. Trusted LASIK Surgeons Welcomes Leading LASIK Eye Surgery Expert, Inventor David Huang, M.D., Los Angeles, to Its Unique Lasik Directory Service
6. ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM)
7. CORD:USE Cord Blood Bank is Proud to Announce that Cord Blood Pioneer and Leading Transplanter Dr. Eliane Gluckman has Joined its Team
8. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
9. Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant
10. Patent Technologies Keep CGMT in a Leading Position in the Industry
11. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. ... the development and commercialization of targeted antiviral therapies, announced ... Investor Conference 2016, to be held February 8-9, 2016, ... Group,s 2016 Disruptive Growth & Healthcare Conference, taking place ... 10-11, 2016. James Sapirstein , Chief Executive ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... supplier of Semantic Graph Database technology has been recognized As “ Best in ... Corporate America Magazine. , “At Corporate America, it’s our priority to showcase prominent ...
(Date:2/3/2016)... DIEGO , Feb. 3, 2016   ... company with the first pluripotent stem cell-derived islet ... diabetes in clinical-stage development, today announced that ViaCyte ... Pharmaceutical Companies of Johnson & Johnson, have agreed ... group into ViaCyte.  The agreement provides ViaCyte with ...
(Date:2/3/2016)... Ascendis Pharma A/S (Nasdaq: ASND ), ... TransCon technology to address significant unmet medical needs, today ... Leerink Partners Global Healthcare Conference Location: , Waldorf ... 2016 Time:  , 11:55am EST www.ascendispharma.com ... An audio webcast of this event will be posted ...
Breaking Biology Technology:
(Date:2/2/2016)... 2016 Technology Enhancements Accelerate Growth of X-ray Imaging ... digital and computed radiography markets in Thailand ... Indonesia (TIM). It provides an in-depth ... well as regional market drivers and restraints. The study ... and market attractiveness, both for digital and computed radiography. ...
(Date:2/1/2016)... , February 1, 2016 Rising ... to drive global touchfree intuitive gesture control market ... Rising sales of consumer electronics coupled with new ... market size through 2020   ... coupled with new technological advancements to drive global touchfree ...
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
Breaking Biology News(10 mins):